Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Atherosclerosis to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Atherosclerosis to Cardiovascular Clinical Trials 22
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Atherosclerosis Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Atherosclerosis 38
Nov 06, 2019: The Medicines company to present inclisiran data from ORION-9 and ORION-10 pivotal phase 3 clinical studies at American Heart Association Scientific Sessions 2019 38
Sep 26, 2019: Medicines Company’s inclisiran meets all endpoints in ORION-10 trial 38
Clinical Trial Profile Snapshots 39
Appendix 714
Abbreviations 714
Definitions 714
Research Methodology 715
Secondary Research 715
About GlobalData 716
Contact Us 716
Source 717
Atherosclerosis Therapeutics, Global, Clinical Trials by Region, 2019* 8
Atherosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
Atherosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Atherosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
Atherosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
Atherosclerosis Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
Atherosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
Atherosclerosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
Proportion of Atherosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 18
Atherosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
Atherosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 21
Proportion of Atherosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 22
Atherosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23
Atherosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25
Atherosclerosis Therapeutics, Global, Clinical Trials by Phase, 2019* 26
Atherosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 27
Atherosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29
Atherosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30
Atherosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31
Atherosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 32
Atherosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34
Atherosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36
Atherosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37
List of Figures
Atherosclerosis Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Atherosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Atherosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Atherosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
Atherosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
Atherosclerosis Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
Atherosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
Atherosclerosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16
Proportion of Atherosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 17
Atherosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
Atherosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
Proportion of Atherosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 22
Atherosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23
Atherosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 24
Atherosclerosis Therapeutics, Global, Clinical Trials by Phase (%), 2019* 26
Atherosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 27
Atherosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 28
Atherosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30
Atherosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31
Atherosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 32
Atherosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 33
Atherosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 35
Atherosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37
GlobalData Methodology 715
【免責事項】
https://www.marketreport.jp/reports-disclaimer